Skip to main content
Premium Trial:

Request an Annual Quote

Born to Play?

At least two companies have begun selling tests that claim to help determine if a child is genetically programmed to play a certain sport, says The Washington Post's Rob Stein. The companies say their tests can set children on a course to playing a sport for which they have "innate skills" and could get scholarships, Stein adds. But critics are calling these tests "questionable" and say that no DNA kit can tell a parent whether their children's genes will influence their athletic prowess. FDA, which is already trying to figure out how to regulate all of the DTC genetic tests flooding the market, has sent a letter to at least one of the companies selling a sports test, demanding an explanation for the company's marketing of the test without FDA authorization, Stein says. "I think this company is a good advertisement for the need for more regulation of genomic testing," Stanford University bioethicist Hank Greely tells Stein.

Our sister publication GenomeWeb Daily News has more on the letters sent by FDA.

The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.